tiprankstipranks
Cognition Therapeutics (CGTX)
NASDAQ:CGTX
US Market
CGTX
Cognition Therapeutics
RESEARCH TOOLSreports

Cognition Therapeutics (CGTX) Financial Statements

617 Followers

Cognition Therapeutics Financial Overview

Cognition Therapeutics's market cap is currently $77.56M. The company's EPS TTM is $-0.037; its P/E ratio is -8.98; Cognition Therapeutics is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -228.00K$ 0.00$ -252.00K$ -235.00K$ 0.00
Operating Income$ -47.80M$ -53.97M$ -50.72M$ -43.55M$ -28.60M
EBITDA$ -47.80M$ -33.68M$ -25.51M$ -21.13M$ -10.73M
Net Income$ -23.49M$ -33.97M$ -25.79M$ 757.00K$ -11.72M
Balance Sheet
Cash & Short-Term Investments$ 36.81M$ 25.01M$ 29.92M$ 41.56M$ 54.72M
Total Assets$ 48.39M$ 30.23M$ 35.16M$ 50.42M$ 59.14M
Total Debt$ 638.00K$ 814.00K$ 1.24M$ 1.48M$ 0.00
Net Debt$ -36.17M$ -24.20M$ -28.68M$ -40.08M$ -54.72M
Total Liabilities$ 14.12M$ 11.48M$ 10.69M$ 10.18M$ 7.86M
Stockholders' Equity$ 34.27M$ 18.75M$ 24.47M$ 40.25M$ 51.27M
Cash Flow
Free Cash Flow$ -24.59M$ -28.48M$ -16.16M$ -18.70M$ -3.66M
Operating Cash Flow$ -24.59M$ -28.47M$ -16.02M$ -18.53M$ -3.63M
Investing Cash Flow$ 9.00K$ -4.00K$ -147.00K$ -171.00K$ -27.00K
Financing Cash Flow$ 36.57M$ 23.57M$ 4.52M$ 5.55M$ 53.20M
Currency in USD

Cognition Therapeutics Earnings and Revenue History

Income Statement >

Cognition Therapeutics Debt to Assets

Balance Sheet >

Cognition Therapeutics Cash Flow

Cash Flow >

Cognition Therapeutics Forecast EPS vs Actual EPS

Earnings >